StockData

Orchestra BioMed Holdings, Inc. (OBIO) income statement

OBIONasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 9/30
$7.46+0.49 (+7.03%)

Close on Nov 18, 2026Market cap $448.38MP/E –Yield –

Orchestra BioMed Holdings, Inc. income statement

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin
99.5%
Operating margin
-181.4%
Net margin
-184.6%
Return on equity, FY2025
–

Financial strength

Current ratio
8.26
Debt to equity
–
Debt to assets
–
Cash to current liabilities
152.0%

Valuation

P/E ratio
–
Price to sales
14.02
Price to book
–
Dividend yield
–

See a number that looks wrong?